Population pharmacokinetics of exendin-(9-39) and clinical dose selection in patients with congenital hyperinsulinism.
about
Population pharmacokinetics of exendin-(9-39) and clinical dose selection in patients with congenital hyperinsulinism.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Population pharmacokinetics of exendin-
@nl
Population pharmacokinetics of ...... th congenital hyperinsulinism.
@en
type
label
Population pharmacokinetics of exendin-
@nl
Population pharmacokinetics of ...... th congenital hyperinsulinism.
@en
prefLabel
Population pharmacokinetics of exendin-
@nl
Population pharmacokinetics of ...... th congenital hyperinsulinism.
@en
P2860
P50
P356
P1476
Population pharmacokinetics of ...... ith congenital hyperinsulinism
@en
P2093
Steven H Seeholzer
Yixuan Zou
P2860
P304
P356
10.1111/BCP.13463
P407
P577
2017-12-06T00:00:00Z